REGENERON PHARMACEUTICALS, INC. (REGN) Net margin 2016–2025
REGENERON PHARMACEUTICALS, INC. (REGN) net profit margin by fiscal year — reported net income divided by reported revenue.
31.4%FY2025 · since FY2016: 18.4% → 31.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 31.4% | +0.3 pp |
| FY2024 | 31.1% | +0.9 pp |
| FY2023 | 30.1% | -5.5 pp |
| FY2022 | 35.6% | -14.6 pp |
| FY2021 | 50.2% | +8.9 pp |
| FY2020 | 41.3% | +9.1 pp |
| FY2019 | 32.3% | -15.2 pp |
| FY2018 | 47.5% | +27.1 pp |
| FY2017 | 20.4% | +2.0 pp |
| FY2016 | 18.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice